Federal Court Holds that Hershey RSRs are Entitled to Overtime

On February 23, 2011, the Honorable Magistrate Bernard Zimmerman, United States District Court for the Northern District of California, issued an order holding that the Hershey Retail Sales Representative (“RSR”) plaintiffs and those RSRs who have joined the case of Campanelli, et al. v. The Hershey Company, Case No. 3:08-cv-01862-BZ, are entitled to overtime compensation. [...]

By | February 23rd, 2011|Hershey Overtime Lawsuit|Comments Off on Federal Court Holds that Hershey RSRs are Entitled to Overtime

Bisphosphonates (Fosamax) Increases Risk of Femoral Fractures

A recent article in the Journal of the American Medical Association (JAMA) has again linked use of bisphosphonates for osteoporosis to increased risk of subtrochanteric and femur fractures.  The drugs in the bisphosphonate family include Fosamax, Boniva, Actonel, Aredia, Zometa, and Reclast. The JAMA article, entitled "Bisphosphonate Use and the Risk of Subtrochanteric and Femoral [...]

By | February 23rd, 2011|Fosamax Osteoporosis Drug|Comments Off on Bisphosphonates (Fosamax) Increases Risk of Femoral Fractures

Louisiana Sues GSK for Avandia Fraud

Louisiana Attorney General Buddy Caldwell has filed suit in a Baton Rouge state court against GlaxoSmithKline claiming that it defrauded Louisiana's Medicaid program out of $36 million in reimbursement payments related to Avandia.  AG Caldwell contends that GSK "wrongfully and illegally marketed, priced, sold and promoted the diabetes medication".  Avandia use has been linked to [...]

By | February 18th, 2011|Avandia Diabetes Drug|Comments Off on Louisiana Sues GSK for Avandia Fraud

78% of Recalled Medical Devices were Approved by the FDA’s Fasttrack Process

An article has been published in the Archives of Internal Medicine attacking the FDA's fast track approval processes that include the 510(k) application for medical devices. "Most medical devices recalled for life-threatening or very serious hazards were originally cleared for market using the less stringent 510(k) process or were considered so low risk that they [...]

By | February 16th, 2011|DePuy Hip Replacement|Comments Off on 78% of Recalled Medical Devices were Approved by the FDA’s Fasttrack Process

FDA to Outsource Inspections of Non-U.S. Pharmaceutical Factories

With the advent of globalization and the move of manufacturing plants off shore, many drug manufacturers have taken advantage of lower costs and shipped American jobs overseas.  Unfortunately the FDA's U.S. based inspectors did not follow overseas to ensure the quality of the products manufacture for consumption in the U.S. In the U.S., FDA inspections [...]

By | February 11th, 2011|Avandia Diabetes Drug, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Yaz Birth Control|Comments Off on FDA to Outsource Inspections of Non-U.S. Pharmaceutical Factories

San Francisco’s Most Dangerous Streets for Bicyclists

San Francisco is certainly a bike-friendly city, but with more bicyclists on the road comes more accidents with motor vehicles. The Bay Citizen has just released its comprehensive bicycle accident study which used information from police reports to determine location and fault of bicycle-related accidents in San Francisco since 2009.  Click here to view the [...]

By | February 8th, 2011|General Interest|Comments Off on San Francisco’s Most Dangerous Streets for Bicyclists

Celebrities and Athletes : PR Ambassadors

American companies with public relations issues have historically turned to celebrities and athletes for advertising help to improve their image or promote their product.  We all remember celebrity endorsements to oppose negative press for asbestos manufacturer Johns Manville and American Express. More recently, pharmaceutical manufacturer Merck turned to Dorothy Hamill and Bruce Jenner to advertise [...]

By | February 3rd, 2011|DePuy Hip Replacement, Drug and Medical Device Litigation|Comments Off on Celebrities and Athletes : PR Ambassadors

A Loophole Allowed the DePuy Hip to be FDA Approved Without Testing

A enlightening article in the New York Times discusses this "Implant Loophole" and how DePuy (owned by Johnson & Johnson) skirted the clinical testing requirement in order to get this product on the market as soon as possible. There is a significant controversy about the recalled DePuy ASR XL replacement hip.  Studies of people that [...]

By | February 2nd, 2011|DePuy Hip Replacement|Comments Off on A Loophole Allowed the DePuy Hip to be FDA Approved Without Testing

Johnson and Johnson Earnings Down Amid DePuy Charge

In recent financial reports Johnson & Johnson, owner of DePuy Orthopaedics, has set aside almost $1 billion to prepare for litigation and settlements related to injured plaintiffs who have used the DePuy hip replacement apparatus.  The litigation nationally is just commencing with the formation of an MDL (multi-district litigation).  It is has been active in [...]

By | February 1st, 2011|DePuy Hip Replacement|Comments Off on Johnson and Johnson Earnings Down Amid DePuy Charge